Good Bye To Cancer / What The Alopathic Doctors Won't Tell You... No One Needs To Die From Cancer... Doctors Are Far More Dangerous Than Gun Owners...

Every cell in the body is like a little
battery.  To successfully bring nourishment in, and take poisons out, it
has to be fully charged.  In a  cancerous cell, the charge
(called  cell voltage) drops from 90 millivolts to less than 40
millivolts.  When the cell voltage gets to  the very bottom, only 5
substances can pass in or out of the cell.  They are water, sugar,
potassium, cesium and rubidium.  Oxygen cannot enter into a cancer
cell.  So you see, even if there is a lot of oxygen in the blood, it
won’t get into the cell.  Cesium, because of its electrical properties
can still enter the cancerous cell.  When it does so, because of it’s
extreme alkalinity, the cell dies.  Luckily, healthy cells are not
affected by cesium because their cell voltage allows them to balance themselves. 
The only side effect is a loss of potassium which can be remedied with eating
a few bananas and potatoes.

     It is interesting to
note that cancer is virtually unknown among the Hopi Indians of Arizona and
the Hunza of Northern Pakistan, so long as they stay in the same
environment.  This strongly suggests that something they are consuming
is protecting them from cancer.  The Hopi water is rich in Rubidium and
potassium.  The Hunza water is rich in Cesium and potassium, making both
of the water supplies rich with very caustically (alkaline) active
metals.  

    In his publication, Cesium therapy in cancer
patients, Dr. Sartori describes the 2 week treatment of 50 last stage,
metastasized, terminal cancer patients  (13 comatose), with Cesium
salts.  All were expected to die within weeks, with the survival rate
being less than one in ten million.  After 2 weeks, 13 died with
autopsies showing no presence of cancer.  After 12 months, 12 more had
died, but 25, an astounding 50% survived.  

*Cesium has no natural radioactive form, and should not be confused
with Cesium 137 which is artificially produced.

    Cancer cells are very weak, far weaker than healthy
cells.  It is very easy to kill cancer cells if you can create the right
environment.  The following protocols are deadly to cancer cells, yet
harmless if not outright beneficial to healthy cells. 

    Cancer cells live in an acidic environment, but
perish in an alkaline, high pH, environment.  Although many diets can
help you alkalinize your body, nothing works as fast as Cesium Carbonate or
Cesium Chloride.

Cesium *, a crystalline salt has been used successfully for cancer for
many years now.  Cesium Chloride and Cesium Carbonate work by raising
the cancer cell’s  Ph to a highly alkaline state.  Although many
anti-cancer diets also produce an alkaline state, they simply cannot do so as
quickly or as fully as Cesium can. 

    Certain foods contain
biologically active compounds and/or ingredients, i.e., vitamins, inorganic
salts, organic compounds, essential fatty acids, minerals, and chelating
agents which may either precipitate or prevent cancer development.  The
relationship between dietary consumption and cancer development is not clear
and further investigation continues.  Noteworthy is the report on the
presence of high levels of cesium [Cs] and rubidium [Rb] in food along with
availability of various supportive compounds as vitamins A and C, along with
zinc and selenium in diet of populations residing in areas with low incidence
of cancer e.g., the Hopi Indian territory in Arizona, the Hunza area in North
Pakistan, and the volcanic regions of Brazil.  The diet of these
populations is similar to the nutritive requirements for the high Ph cancer
therapy developed by Brewer’s subsequent series of physical experiments with
cancer cells.  In these tests the presence of Cs+ or Rb+ in the adjacent
fluids of the tumor cell is believed to raise the Ph of the cancer cell where
mitosis will cease resulting in reduction of life span of the cancer
cell.  The introduction of such alkaline pH by these alkali salts may
also neutralize the acidic and toxic material within the cancer cell. 
This report combines the use of CsCl with various supportive agents. which
have been hypothesized both to enhance the entry of Cs+ into the cancer cell
and to stimulate the immune response, in the treatment of various cancers.

    Treatment was performed on
50 patients during the last  three years at Life Sciences Universal
Medical Clinics in Rockville MD and in Washington D.C.  All patients
were terminal subjects with generalized metastatic disease.  Forty-seven
of the 50 patients studies had received maximal modalities of treatment,
i.e., surgery, radiation, and various chemotherapy, before metabolic
Cs-treatment was initiated.  Three patients were comatose and 14 of the
patients were considered terminal due to previous treatments outcome and
cancer complications.  The type of cancer of the patients studied and
their number is detailed in table 1.

    The Cs-treatment was given
in conjunction of other supportive compounds under diet control in addition
to the utilization of specific compounds to produce adequate circulation and
oxygenation.  According to individual cases CsCl was given at daily
dosages of 6 to 9 grams in 3 equally divided doses, with vitamin A-emulsion
(100,000 to 300,000 U), vitamin C (4 to 30 grams), zinc (80 to 100 mg)
selenium (600 to 1,200 mcg) and amygdalin (1,500 mg) in addition to other
supplementations according to the specific needs of the patient.  The
diet consisted mainly of whole grains, vegetables, linolenic acid rich oils
(linseed, walnut, soy, wheat germ) and other supplemental food.  To
increase efficiency of the treatment and improve the circulation and
oxygenation, the patients received the chelating agent EDTA,
dimethylsulfoxide (DMSO) and also a combination of vitamins, K and Mg salts.

    Table 1 summarizes the
results of the Cs-treatment of 50 cancer patients studied over 3 years. 
They had generalized metastatic disease, except for 3 patients.  Initial
death occurrences for the initial 2 week treatment was in the same order and
magnitude of these recorded for the 12 month period.   The percent
of survival of breast, colon, prostate, pancreas, and lung cancer accounted
to approximately, 50% recovery which was higher than that noted for liver
cancer and the lymphoma patients treated.  An overall 50% recovery from
cancer by the Cs-therapy was determined in the 50 patients treated. 
Data from the autopsy made indicated the absence of tumors in patient dying
within 14 days of the Cs-treatment.  One of the most striking effects of
the treatment was the disappearance  of pain in all patients within 1 to
3 days after initiation of the Cs-therapy.  

    These studies were
performed under my direction, initiated in April, 1981.  Twenty-eight
patients were initially treated with CsCl between April, 1981 to October,
1982.  They were subjected to various cancer therapies, e.g., surgery,
radiation, and chemotherapy, and were considered terminal cases with
metastatic disease except for 3 patients who were not previously
treated.  Three patients were comatose at the time of the Cs
treatment.  Thirteen patients died within less than 2 weeks of
treatment.  Each patient showed a reduction in tumor mass by the
Cs-treatment.  Of the breast cancer patients, the most impressive effect
was seen in a female patient who was comatose at the beginning of the
Cs-treatment and was considered a terminal case.  The Cs-therapy, with
other ingredients used, was immediately instituted by nasogastric route
because there was no cooperation from the patient.   The daily CsCl
dose given amounted to 30 grams, 10 grams given 3 times daily.  The
patient was able to leave after 5 days of treatment.  However the
patient’s fall on the floor resulted in complications, i.e., fracture of the
neck, and death.  The autopsy revealed that the cancer metastasis had
essentially eaten away her hip bone causing this tragic accident.  The
autopsy performed also showed the presence of very little cancer tissue.

     The next most
frequent cancer treated was of unknown primary.  Treatment of 8 cases showed
a death rate of 2 within 14 days of treatment and an additional 2 deaths
within 12 months while 4 of the patients are still living.  In one case,
an autopsy was made in a patient after one week of Cs-treatment and showed a
complete disappearance of the cancer.  There were 7 cases of colon
cancer patients who were treated with CsCl.  Two of these patients died
within 14 days, one of the patients had previous massive chemotherapy, and
little time was available to restore her metabolic condition.  The previous
existing infiltration of the abdominal wall disappeared.  However, no
consent was given for an autopsy.

     In one lymphoma case
the patient displayed an unusually large abdomen  which was hard and he
weighed approximately 250 pounds.  The massively enlarged abdomen began
to decline in volume, i.e., a loss of approximately 120 pounds of body weight
was noted after 3 months of the Cs- therapy.  The spleen which was
originally maximally enlarged and reaching into the pelvis was reduced to
almost normal size.  The liver position was down to about the level of
the umbilicus and was also reduced to normal size in 3 months.  The
patient is still living after 3 years after his discharge. 
Unfortunately, there is no follow-p on this patient and he is being maintained
on chemotherapy.

       The
results presented demonstrate the rate of efficacy of CsCl in cancer
therapy.  The total 50 cancer cases studied show an impressive 50%
survival rate.  This confirms the work of Messiha reported in these proceedings
showing that the higher the dose it is, the more effective it seems to
be.   The autopsy obtained from the patient whose death was 
attributed to traumatic fracture of the neck, indicated that cancer had been
initially further advanced resulting in bone destruction.  However, the
absence of cancer after the massive CsCl dose used in this case is
demonstrable of the Cs-therapy.  It appears that both dosage, i.e., as
much as 30 grams/day and route of drug administration, i.e., nasogastric
pathway, might have contributed  to the patients  rapid
recovery.  It should be noted, however, that CsCl dose regimens should
not exceed 20 to 40 grams due to side effects, mainly nausea, and
diarrhea.  The authors personal experience with CsCl after an acute dose
of 40 grams CsCl indicate that extensive nausea and parethesia around the
mouth are the major side effects.  This is probably due to K
depletion.  The usual dose used in the clinic ranges from 2 to 3 grams
given by mouth 3 times daily.  At a later time, at which time there is
no indication of cancer presence, the CsCl dosage will be reduced to a
preventative dose between .5 and 1 gram a day.

     The lymphoma case
presented shows that CsCl efficiently reduced massive enlargements of spleen
and liver as well as maximal ascites, causing an abdominal configuration of a
tight, hard hemisphere, to almost normalize after 3 months of therapy. 
This period of time was required to eliminate such a massive volume resulting
in the reduction of the body weight noted.

     The clinical
efficacy of CsCl high pH metabolic therapy is best demonstrated by a recent
case of primary liver cancer (not included in the 50 cases reported in this
study).  The patient was a 39 year old female teacher who was terminal. 
She was brought on a stretcher on April 25, 1984 with a large liver tumor
extending approximately 3 cm below the umbilical level.  The treatment
was then immediately instituted.  This consisted of administration of
CsCl, Beta-carotene, Vitamin C, Zn, Se, Mn, Cr, and K salts by the oral route
in addition to a concomitant massive IV doses of ascorbate, K, Mg, Zn, Cn,
Mn, Cr salts, B complex vitamins, folic acid, DMSO and heparin.  After 5
consecutive treatment regimens EDTA was introduced to the therapy and the
minerals present in the solution were discontinued.  On May 10, 1984,
the patient was discharged, returned home walking without assistance and
displaying a smile on her face.  The liver tumor had shrunk to 5 cm
above the umbilicus.   The determination of alphafetoprotein (AFP),
a specific marker for liver cancer, rare embronal cancer and teratomas,
decreased from the unusually high value of 39,000 units, compared to normal
levels of 13 units, measured before initiation of Cs-therapy, to 5000 units
obtained on the last day of treatment.

    The mechanism of action of
Cs in cancer has been little studied.  Both Cs+ and Rb+ can specifically
enter the cancer cells and embryonic cells, but not normal adult cells has
been demonstrated by Brewer.  The cancer cells contain high amounts of
hydrogen ions rendering them acidic and they also contain high Na+ levels
than found in normal cells.  If Cs+ or Rb+ can enter the cancer cells
then the pH increases from as low as 5.5 to over pH 7.0.  At a pH of 7.6
the cancer cell division will stop, at a pH of 8.0 to 8.5 the lifespan of it
is considerably shortened (only hours).  In one case, the author has
observed the shrinkage of metastases of breast cancer after one hour of
Cs-treatment.  Two days later wrinkles of the skin appeared where the
tumor was present.  In another case of a colon cancer with massive
metastasis, of massive infiltration of the abdominal wall, liver and other
tissues, seemed to have been  reduced  within 24 hours and
continuing rapidly until the demise of the patient on the 14th day of the
Cs-treatment.

     The uric acid levels
measured at the onset of treatment was approximately 3.5 units which was
increased to over 20 units, suggesting massive breakdowns of DNA, which
produces the uric acid output.  Therefore,
destruction of nuclear acids, as reflected by a significant rise in the uric
acid, may be used as a predictive measurement for treatment outcome. 
The failure of uric acid elevation may be indicative of lack of destruction
of cancer cells.  This has proven to be a very consistent finding in our
clinic.

     There are certain
factors which may enhance the Cs-therapy.  The Cs-penetration into the
cancer cells can be increased by the following three methods:  The first
approach resides in broadening the electron donor capacity of the cancer cell
membrane by the application of cyanide, an electron donor radical as found in
nitriles (amygdalin, Laetrile, mandelonitrite, prunasin, ficin, cassivin), by
selenium oxide, an electron donor radical, or by the use of DMSO.  The
second approach enhances the potential gradient across the cancer cell
membrane by the utilization of weak acids like ascorbic acid (Vitamin C) and
retinoic acid (Vitamin A).  The third method attempts to improve the
circulation to the tumor and facilitate the destruction of cross-linkages in
the mucoid and fibrinous substances around the cancer cell.  This can be
achieved by chelation therapy, i.e., the use of EDTA as has been shown by
Blumer who reported  on the reduction of cancer incidence by 90% by
chelating patients (an average of 15 chelations in 8 years).  This
approach also reduced cardiovascular disease by 50%.  Other chelating
agents can also be used.  Moreover, the use of beta-carotene will lead
to decomposition of blocking mucoid proteins mediated by electrical
charges;  Also, heparin, which acts through electrical charges, will
inactivate the immune repelling and immune binding capacities of the blocking
mucoid proteins.  These approaches will hinder cancer growth and they
are virtually atoxic.

    It should be noted that
certain behavioral characteristics “the cancer personality” of the
cancer patient may interfere in any projected treatment modality.  This
has been reported by Lawrence LeShan in his book entitled “You can fight
for your life.”  His studies suggested that cancer patients seeking
treatment, e.g., chemotherapy, radiation or surgery, are probably motivated
by a covert desire for death.  For example, statements such as,
“rather than undergoing any of those treatments, I would rather die in
peace,” or “I would never undergo any of those treatments or let
anyone of my family undergo them because the effectiveness is unproven and
the damage that is done with any of those treatments is higher than the
effects.” are often expressed.  Thus, both chemotherapy and
lifestyle changes may also contribute to an effective therapy.

     Nobel Laureate Otto Warburg demonstrated that normal
cells would become irreversibly cancerous if the environment they rested in
had their oxygen levels lowered by 35% for 48 hours.